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Interaction between prenatal pesticide
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the PON1 gene on DNA methylation in
genes associated with cardio-metabolic
disease risk—an exploratory study
Ken Declerck1, Sylvie Remy2,3, Christine Wohlfahrt-Veje4, Katharina M. Main4, Guy Van Camp5, Greet Schoeters3,6,7,
Wim Vanden Berghe1 and Helle R. Andersen7*
Abstract
Background: Prenatal environmental conditions may influence disease risk in later life. We previously found a gene-
environment interaction between the paraoxonase 1 (PON1) Q192R genotype and prenatal pesticide exposure leading
to an adverse cardio-metabolic risk profile at school age. However, the molecular mechanisms involved have not yet
been resolved. It was hypothesized that epigenetics might be involved. The aim of the present study was therefore to
investigate whether DNA methylation patterns in blood cells were related to prenatal pesticide exposure level, PON1
Q192R genotype, and associated metabolic effects observed in the children.
Methods: Whole blood DNA methylation patterns in 48 children (6–11 years of age), whose mothers were
occupationally unexposed or exposed to pesticides early in pregnancy, were determined by Illumina 450 K
methylation arrays.
Results: A specific methylation profile was observed in prenatally pesticide exposed children carrying the PON1
192R-allele. Differentially methylated genes were enriched in several neuroendocrine signaling pathways
including dopamine-DARPP32 feedback (appetite, reward pathways), corticotrophin releasing hormone signaling,
nNOS, neuregulin signaling, mTOR signaling, and type II diabetes mellitus signaling. Furthermore, we were able to
identify possible candidate genes which mediated the associations between pesticide exposure and increased
leptin level, body fat percentage, and difference in BMI Z score between birth and school age.
Conclusions: DNA methylation may be an underlying mechanism explaining an adverse cardio-metabolic health
profile in children carrying the PON1 192R-allele and prenatally exposed to pesticides.
Keywords: DNA methylation, Prenatal pesticide exposure, Paraoxonase 1, PON1 Q192R genotype, Illumina 450 K
methylation array, Cardio-metabolic health
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Background
A considerable part of modern pesticides has neurotoxic
and/or endocrine disrupting properties [1–3] and therefore
the potential to disturb development of neurobehavioral,
neuroendocrine, and reproductive functions [4–8] espe-
cially if exposure occurs during vulnerable time periods in
fetal life or early childhood. To investigate potential health
effects of prenatal pesticide exposure, we have followed a
cohort of children, whose mothers were employed in green-
house horticulture in pregnancy. Some of the mothers were
occupationally exposed to mixtures of pesticides in the first
trimester before the pregnancy was recognized, and pre-
ventive measures were taken. Findings from this cohort
include associations between maternal pesticide exposure
and lower birth weight followed by increased body fat accu-
mulation during childhood [9], impaired reproductive de-
velopment in boys [10, 11], and earlier breast development
[12] and impaired neurobehavioral function in girls [13].
The HDL-associated enzyme paraoxonase 1 (PON1)
catalyzes the hydrolysis of a wide range of substrates
including some organophosphate insecticides [14, 15].
It also protects lipoproteins from oxidative modifica-
tions and hence against development of atherosclerosis
[16, 17]. A common polymorphism in the coding se-
quence of the PON1 gene substitutes glutamine (Q) to
arginine (R) at position 192. This substitution seems to
affect both properties of the enzyme, and several stud-
ies have indicated an increased risk of cardiovascular
disease in R-allele carriers [17, 18]. To investigate if this
polymorphism affected the sensitivity to prenatal pesti-
cide exposure, the PON1 Q192R genotype was deter-
mined in the children. We found a marked interaction
between prenatal pesticide exposure and the PON1
Q192R genotype. At school age, exposed children with
the R-allele had significantly higher BMI, body fat per-
centage, abdominal circumference, and blood pressure
compared to unexposed children with the same genotype.
In the group of children with the QQ genotype, there was
no effect of prenatal pesticide exposure on these parame-
ters [19]. In addition, serum concentrations of leptin, glu-
cagon, and plasminogen activator inhibitor type-1 (PAI-1)
were enhanced in prenatally pesticide exposed children
with the R-allele, also after adjusting for BMI [20] which
also indicates disturbance of metabolic pathways related to
development of metabolic syndrome [21–23]. In addition,
leptin seemed to be a mediator of the increased fat accu-
mulation during childhood related to prenatal pesticide ex-
posure in children with the PON1 192R-allele [20]. Thus,
the obtained results indicate a gene-environment inter-
action between pesticide exposure and PON1 gene hetero-
geneities already in early prenatal life that might enhance
the risk of cardio-metabolic diseases later in life.
The mechanism behind this interaction is not yet under-
stood but might be mediated by epigenetic alterations
depending on both genotype and prenatal exposure.
Epigenetic marks, including DNA methylation and cova-
lent histone modifications, are dynamic and can adapt to a
variety of external stimuli [24]. Furthermore, during fetal
development extensive de- and re-methylation events are
taking place making this period highly vulnerable for
epigenetic changes caused by environmental conditions
[25]. Indeed, emerging evidence in experimental animals
and in humans associate altered DNA methylation pat-
terns with a variety of prenatal exposures including dietary
factors, parental care, infections, smoking, and environ-
mental pollutants [26–31]. In experimental animals, early
life changes in DNA methylation have been associated
with diet-induced obesity and insulin resistance [32].
Recently, also human studies have suggested that DNA
methylation patterns at birth are related to birth weight
and fat mass later in childhood [33, 34]. The aim of this
exploratory study was to investigate whether methylation
patterns in blood samples of school children were related
to prenatal pesticide exposure, PON1 Q192R genotype,
and adverse health outcomes already observed in the chil-
dren. We hypothesized that the health effects associated
with early prenatal pesticide exposure were related to
differential epigenetic modifications in children with the
QQ-genotype and children carrying the R-allele.
Methods
Study population
This study is a part of an ongoing prospective study
including 203 children born between 1996 and 2001 by
female greenhouse workers. The children were examined
for the first time at 3 months of age [11] and followed-
up at school age when 44 new age-matched controls
were included [9], and the PON1 genotype was deter-
mined for 141 children [19]. For this exploratory study,
48 pre-pubertal (Tanner Stage 1) children, whose
mothers reported not to have smoked during pregnancy,
were selected equally distributed between the PON1
192QQ and QR/RR genotype. The QR/RR genotype
group consisted of 3 children with the RR genotype and
21 with the QR genotype. After excluding children of
mothers who smoked in pregnancy, the number of
unexposed controls within each genotype was low, 20
with the QQ genotype and 16 with the QR/RR genotype.
DNA qualified for methylation analysis was only avail-
able for 11 and 12 of these children, respectively. For
each genotype, we then used individual matching to
select one exposed child of same sex and age for each of
the controls. For the QQ-genotype, two exposed chil-
dren were selected for each of two controls to obtain 24
children. Thus, in total we used data from 13 exposed
and 11 unexposed children with the QQ genotype, and
12 exposed and 12 unexposed children with the QR/RR
genotype (Table 1).
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Recruitment, characteristics, exposure categorization,
and clinical examinations of the children have previously
been described in detail [9, 11, 19]. Briefly, we recruited
pregnant women working in greenhouses and referred
to the local Department of Occupational Health for risk
assessment of their working conditions and guidance for
safe work practices during pregnancy. Detailed informa-
tion about working conditions inclusive pesticide use for
the previous 3 months was obtained from maternal
interview at enrollment (gestational weeks 4–10) and
supplemented by telephone contact to the employers.
For all women, re-entry activities (such as moving or
packing potted plants or nipping cuttings) constituted
their main work functions. Approximately 20% of the
women reported having been directly involved in apply-
ing pesticides, mainly by irrigating fungicides or growth
retardants. Only few (6%) of the women had applied
insecticides. The women were categorized as occupa-
tionally exposed if pesticides were applied in the working
area more than once a month, and the women handled
treated plants within 1 week after treatment and/or the
women were directly involved in applying pesticides.
The women were categorized as occupationally unex-
posed if none of the above criteria was fulfilled. All
exposure assessments and categorization of the mothers
as pesticide exposed or unexposed were performed inde-
pendently by two toxicologists before the first examination
of the children. Women categorized as pesticide exposed
went on paid leave or were moved to work functions with
less or no pesticide exposure shortly after enrollment.
Hence, the exposure classification relates to the early
weeks of the first trimester before study enrollment.
The exposure situation was complex since the use of
specific pesticides varied with time and location, both
within the same company and between companies, de-
pending on the plant production and the type of pest to
be controlled. Out of 124 different active pesticide ingre-
dients used in the greenhouses were 59 insecticides (17
organophosphates, 12 pyrethroids, 9 carbamates, and 21
others), 40 fungicides, 11 growth regulators, and 14 her-
bicides. Some were used only in few greenhouses or in
short periods, whereas others were used more often.
Organophosphate insecticides were used to some extent
in the working areas for 91% of the exposed mothers in
the entire cohort, and for 24 out of the 25 exposed
mothers whose children were included in this study. The
most used organophosphates were dichlorvos, dimetho-
ate, and chlorpyrifos. Other frequently used pesticides
Table 1 Population characteristics and anthropometric data for 48 pre-pubertal children examined at age 6–11 years stratified by
PON1 Q192R genotype and prenatal pesticide exposure
PON1 192QQ PON1 QR/RR
Unexposed Exposed Unexposed Exposed
N 11 13 12 12
Female sex 5 (45.5) 7 (53.8) 6 (50.0) 6 (50.0)
Maternal smoking in pregnancy 0 (0) 0 (0) 0 (0) 0 (0)
SESa 7/4 (63.6/36.4) 3/10 (23.1/76.9)* 5/7 (41.7/58.3) 2/10 (16.7/83.3)
Birth weight (g) 3640 (2600; 5412) 3382 (2750; 4573) 3789 (2984; 4345) 3500 (2900; 3914)*
Gestational age (days) 276 (257; 291) 283 (265; 295) 283 (261; 298) 281 (266; 291)
Age (years) 7.6 (6.2; 9.8) 8.4 (6.7; 10,0) 7.8 (6.6; 9.5) 7.7 (7.1; 9.4)
Height (cm) 133.3 (117.3; 145.2) 130.3 (109.7; 139.2) 130.9 (113.7; 149.1) 128.6 (119.3; 142,5)
Weight (kg) 30.9 (18.7; 38.0) 28.3 (18.0; 30.7) 26.3 (19.9; 36.5) 27.4 (19.5; 37.8)
BMI (kg/m2) 16.2 (13.7; 20.5) 15.3 (14.9; 18.3) 15.5 (13.8; 16.9) 15.7 (13.8; 19.7)
BMI Z scores 0.66 (−1.03; 3.21) −0.18 (−0.80; 1.49) −0.04 (−1.31; 0.89) −0.01 (−0.98; 3.14)
Delta BMI Z score since birth −0.45 (−2.15; 2.97) −0.71 (−2.57; 1.87) −0.56 (−2.52; 1.03) 0.95 (−2.08; 2.97)*
Abdominal circumference (cm) 60.4 (52.0; 75.8) 58.7 (52.1; 66.8) 58.3 (52.0; 68.1) 60.8 (51.8; 70.6)*
Sum of four skin folds (mm) 38.4 (27.1; 85.4) 33.6 (25.4; 54.5) 34.0 (20.2; 45.2) 44.6 (28.8; 72.0)*
Systolic blood pressure (mmHg) 98.7 (93.7; 110.4) 97.2 (84.3; 105.3) 99.7 (84.7; 106.8) 101.7 (91.0; 108.6)
Diastolic blood pressure (mmHg) 54.7 (46.0; 69.9) 56.2 (46.0; 62.0) 56.3 (49.3; 69.1) 63.0 (57.3; 73.1)**
Leptin (ng/ml) 1.47 (0.70; 9.18) 4.40 (0.60; 15.29) 1.41 (0.67; 5.90) 4.69 (1.79; 12.25)**
Insulin (ng/ml) 0.36 (0.22; 1.15) 0.52 (0.23; 2.55) 0.34 (0.16; 1.62) 1.11 (0.24; 7.10)*
Paraoxonase activity (nmol/min/ml) 27.5 (9.9; 38.0) 30.9 (21.0; 38.9) 58.6 (41.9; 68.7) 59.6 (50.3; 71.5)
aSES socioeconomic status (social class 1–3/4–5). Differences between unexposed and exposed children for each PON1 Q192R genotype were tested using
Mann-Whitney U test for continuous variables and Fisher’s exact test (dichotomous variables) or Likelihood ratio (categorical variables with > 2 categories).
*P value ≤ 0.05, **P value ≤ 0.01. Values are presented as median (5–95%) for continuous variables and as N (%) for categorical variables
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were the pyrethroid insecticides deltamethrin and fenpro-
pathrin; the carbamate insecticides methiocarb, pirimi-
carb, and methomyl, and the fungicides fenarimol,
prochloraz, tolclofos-methyl, vinclozolin, iprodion, and
chlorothalonil. In general, the time interval between
applying insecticides and working in the treated areas was
longer (1–3 days) than for fungicides and growth regula-
tors (often a few hours). Because of the complexity of the
exposure situation and because most of the women at
enrollment had been off work for some days while the risk
assessment of their working conditions was performed,
biomonitoring of the exposure was not feasible. A
complete list of the pesticides used in the greenhouses can
be obtained from the corresponding author.
At follow-up at age 6 to 11 years, 177 children under-
went a standardized clinical examination in which
systolic and diastolic blood pressure, pubertal staging,
height, weight, thickness of skin folds, and other an-
thropometric parameters were measured [9]. The same
pediatrician performed all clinical examinations blinded
to information about maternal pesticide exposure during
pregnancy.
Venous non-fasting blood samples were collected
(between midmorning and late afternoon) in EDTA-
coated and uncoated vials (Venoject). After centrifuga-
tion at 2000 g for 10 min at 20 °C, buffy coat for
genotyping and epigenetic analysis was separated from
the EDTA-treated samples. Buffy coat and serum from
the uncoated vials were stored at −80 °C until analysis.
As previously described [19], C-108T (rs705379) and
Q192R (rs662) polymorphisms of the PON1 gene was de-
termined by the Taqman-based allele discrimination using
the ABI Prism 7700 Sequence Detection System, serum
activity of PON1 was determined by spectrophotometry
with paraoxon as substrate, and insulin (proinsulin and
insulin) and leptin concentrations in serum were deter-
mined by commercial ELISA hormone kits from RayBio.
Genotyping and all serum analyses were performed
blinded to both exposure information and examination
outcomes.
Sample preparation
DNA from buffy coat samples was extracted using
QIAamp DNA Blood Mini Kit (Qiagen, Hilden,
Germany). The blood spin protocol was applied ac-
cording to manufacturer’s instructions. Samples were
eluted in 100 μl elution buffer. DNA samples were
bisulfite-converted using the EZ DNA methylation kit
from Zymo according to manufacturer’s instructions.
Successful bisulfite conversion was checked using a
bisulfite-specific PCR of an amplicon in the SALL3
gene (see Additional file 1 for primer sequences). Only
samples showing an intense band on agarose gel were
further analyzed by the 450 K methylation array. As a
negative control non-converted gDNA was used.
DNA methylation and data preprocessing
The Infinium HumanMethylation450 BeadChip array
(Illumina, San Diego, CA, USA) was used to measure
DNA methylation genome-wide. 4 μL of bisulfite-
converted DNA from each sample was amplified, frag-
mented, precipitated, resuspended, and subsequently
hybridized onto the BeadChips. After overnight incuba-
tion of the BeadChips, unhybridized fragments were
washed away, while hybridized fragments were extended
using fluorescent nucleotide bases. Finally, the Bead-
Chips were scanned using the Illumina iScan system to
obtain raw methylation intensities for each probe.
We used the R package RnBeads to preprocess the
Illumina 450 K methylation data [35]. Cg-probes were
filtered before normalization based on following criteria:
probes containing a SNP within 3 bp of the analyzed
CpG site, bad quality probes based on an iterative
Greedycut algorithm where a detection p value of 0.01
was set as a threshold for an unreliable measurement,
and probes with missing values in at least one sample.
After filtering these cg-probes, beta values (ratio of
methylated probe intensity versus total probe intensity)
were within-array normalized using the beta mixture
quantile dilation (BMIQ) method [36]. Another filtering
step was performed after normalization based on the
following criteria: probes measuring methylation not at
CpG sites and probes on sex chromosomes. The two
filtering steps removed a total of 20,338 cg-probes and
ended up with a data set of normalized methylation
values for 465,239 cg-probes. Beta values were trans-
formed to M values (M = log2(β/(1−β))) prior to further
analyses. Principal component analysis (PCA) was
conducted to detect possible batch effects. Associations
between the first eight principal components and
possible batch effect covariates were measured. The
Kruskall-Wallis test was used to find associations with
sentrix_ID (BeadChip), while the two-sided Wilcoxon
sum rank test was used for associations with the pro-
cessing date, exposure and PON1 Q192R genotype.
Significant associations between principal component 2
and sentrix_ID (BeadChip) and processing date were
suggestive for batch effects and were therefore corrected
using the ComBat function in the SVA R package [37]
(Additional files 2 and 3). Raw and normalized array
data were uploaded to the Gene Expression Omnibus
(GEO) database and have accession number: GSE90177.
For each sample, the relative cell type contribution
was measured using the approach described by House-
man et al. [38]. Reference methylomes of each blood cell
type (granulocyte, CD4+ T-cell, CD8+ T-cell, B-cell,
monocyte, NK-cell) were obtained from the study of
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Reinius et al. using the FlowSorted.Blood.450 K R pack-
age [39]. The analysis was limited to the 100,000 most
variable sites. The top 500 cg-probes associated with the
cell types were used to estimate the relative cell type
composition in each sample. One-way ANOVA was used
to determine differences in relative cell type composition
between the exposed and the unexposed children and
between children with the QQ and QR/RR genotype. As-
sociations between relative cell type composition and
health outcomes (percentage body fat, delta BMI z-scores
from birth to school age, and BMI Z scores), leptin levels
and age were analyzed using simple linear regression.
Statistical analysis
Differential methylation was analyzed both at the single
CpG site level and at the region level (Fig. 1). At the single
CpG site level, multiple linear regression (Matlab version
2014b, The Mathworks®, Natick, MA, USA) was per-
formed in which methylation was the dependent variable
and PON1 Q192R genotype and prenatal pesticide expos-
ure (yes/no) were the independent variables. Our statis-
tical approach was designed to explain—at the level of
methylation—the previously reported gene-environment
interaction between the paraoxonase 1 (PON1) Q192R
genotype and prenatal pesticide exposure leading to an
adverse cardio-metabolic risk profile at school age among
children carrying the R-allele [19]. Thus, our primary
interest was to identify methylation marks associated with
exposure that were more altered in R-allele carriers than
in QQ-homozygotes. Two statistical models were included
in our statistical approach. In the first model, effect modi-
fication (interaction) of exposure by PON1 Q192R geno-
type was allowed by including main effects (exposure and
genotype) and cross-product terms (exposure*genotype)
in the models. Statistical significant effects of exposure in
the PON1 192QR/RR group were defined as follows: P
value interaction term ≤0.1 and P value of exposure in
the QR/RR group ≤ 0.001. This model allows studying
synergistic effects where the combined effect of pre-
natal exposure and in the QR/RR group is greater than
the sum of the effects of each factor alone. In the sec-
ond model, effect modification of exposure by PON1
Q192R genotype was not assumed (no cross product
term included). Statistical significant effects of exposure
were defined as follows: P value of exposure ≤0.001, P value
of PON1 genotype ≤ 0.1. In this model the combined effect
of exposure and being R-allele carrier is equal to the sum of
the effect of each factor separately. For both models, the
associations were adjusted for child sex. To identify probes
that were most aberrant in the exposed QR/RR group, we
set an additional filter for both models in which we defined
that the prenatally exposed QR/RR group should either be
highest or lowest methylated (based on mean methylation
level) as compared to the other three groups (exposed QQ,
unexposed QR/RR and unexposed QQ). These sites are
defined as significantly differentially methylated positions
(sig-DMPs) in the remainder of this text. Sig-DMPs were
annotated using the HumanMethylation450 v1.2 manifest
file. The freely available EpiExplorer tool was used to add
further annotation including chromatin state segmentation
and histone modifications based on the UCSC hg19
browser [40]. Genomic locations of transcription factor
binding sites (TFBS) were directly downloaded from the
UCSC h19 genome browser. Enrichment or depletion of
sig-DMPs in a particular genomic region was determined
using the Fisher’s exact test.
Fig. 1 Analysis workflow. Differentially methylated genes were detected using a single CpG and a region-based approach. Only sig-DMPs and
sig-DMRs were selected in which the pesticide exposed QR carrier group was either hyper- or hypomethylated in comparison with the other
groups (interesting profile). By overlapping the sig-DMPs with the sig-DMRs a high confidence list of differentially methylated genes could
be generated
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Differentially methylated regions (DMRs) were detected
using the limma-based DMRcate R package [41]. We only
looked for regions differentially methylated between the
exposed QR/RR group and one of the other groups
(exposed QQ, unexposed QR/RR and unexposed QQ). In
line with identification of sig-DMPs, significant regions
(Padj value < 0.05) were selected in which the exposed R-
allele carriers showed either the highest or the lowest
methylation state which are called sig-DMRs in the
remainder of this text. P values were corrected for mul-
tiple testing using the Benjamini-Hochberg method (Padj).
Pyrosequencing
We used bisulfite pyrosequencing to further verify the
methylation differences observed in the methylation
array. We selected regions in four genes that are known
to be involved in metabolism: LEP, GPR39, PPARG, and
OPCML (Additional file 4). LEP DNA methylation has
been associated with BMI, birth weight, and cholesterol
levels [42–44]. Also, maternal conditions have an effect
on the methylation status of the LEP promoter [45–48].
GPR39 belongs to the ghrelin receptor family and was
shown to be associated with obesity [49]. PPARG is a
nuclear receptor involved in regulation of lipid and
metabolism as well as a target for some obesogenic
endocrine disruptors [20, 50–53]. Furthermore, PPARγ
is directly involved in the regulation of PON1 gene
expression [54–56]. OPCML (Opioid Binding Protein/
Cell Adhesion Molecule-like) is a member of the IgLON
family. A SNP in the OPCML gene was associated with
coronary artery calcified plaque in African Americans
with type 2 diabetes [57]. A mouse and human GWAS
analysis identified an OPCML SNP associated with obes-
ity traits and visceral adipose/subcutaneous adipose
ratio, respectively [58, 59]. 1 μg DNA from each sample
was bisulfite-converted using the EpiTect Fast bisulfite
Conversion Kit (Qiagen, Hilden, Germany) according to
manufacturer’s instructions. 15 ng of bisulfite-treated
DNA was subsequently used in PCR amplification using
the PyroMark PCR Kit (Qiagen, Hilden, Germany).
Reverse primers were biotinylated to get biotin-labeled
PCR products. Finally, DNA sequences were pyrose-
quenced using the PyroMark Q24 Advanced instrument
(Qiagen, Hilden, Germany). First, streptavidin-coated
Sepharose beads (High Performance, GE Healthcare,
Uppsala, Sweden) were used to immobilize the biotin-
labeled PCR products. Subsequently, PCR products were
captured by the PyroMark vacuum Q24 workstation,
washed and denaturated. The single stranded PCR prod-
ucts were mixed and were annealed with their corre-
sponding sequencing primer. After the pyrosequencing
run was finished, the results were analyzed using the Pyro-
Mark Q24 Advanced software (Qiagen, Hilden, Germany).
Biotinylated-reverse, forward, and sequencing primers
were designed using the PyroMark Assay Design 2.0
software (Qiagen, Hilden, Germany) (Additional file 1).
Mediation analysis
For a subset of sig-DMPs and sig-DMRs we analyzed (1)
whether methylation is a mediator between exposure in
PON1 192R-allele carriers and leptin levels; and (2)
whether methylation is a mediator between exposure in
PON1 192R-allele carriers and body fat accumulation
(using delta BMI-score (from birth to school age), and
percentage body fat as endpoints). Mediation analysis
was restricted to the subset of the methylation data that
overlap between the list of sig-DMPs (interaction model)
and sig-DMRs. The analysis was performed by the pro-
cedure described by Baron and Kenny (1986) [60].
Leptin concentrations were logarithmically (ln) trans-
formed prior to analysis. In mediation analysis consider-
ing body fat percentage and leptin, the models were
adjusted for sex. As sex was already considered when
calculating BMI Z score, associations considering medi-
ation between pesticide exposure and BMI Z score were
not adjusted for sex.
To demonstrate mediation, four requirements must be
met: (model 1) the dependent outcome variable (leptin or
a body fat measure) should be significantly associated with
pesticide exposure (independent variable); (model 2) the
DNA methylation mark (mediator) should be significantly
associated with pesticide exposure; (model 3) the
dependent variable should be significantly associated with
the DNA methylation mark; and (model 4) the DNA
methylation mark should be a significant predictor of the
outcome variable, while controlling for pesticide exposure.
The estimated exposure-related change in the outcome
variables in model 4 should be less than in model 1 to
demonstrate partial mediation, and drop to zero to dem-
onstrate full mediation. A P value below 0.05 was used as
a cut-off for statistical significance in each of the models.
Functionally relevant mediators, i.e., mediators that have
been reported to be involved in development of weight
gain/obesity, insulin resistance/diabetes, cardiovascular
disease, and/or fetal growth retardation were subjected to
further statistical analysis. R-package “mediation” was
used to calculate the significance of the causal mediation
effect using a bootstrapping approach [61]. It should be
noted that the age of the children varied between 6 and
11 years at the follow-up examination where blood was
collected. As child age might affect methylation levels, the
exposed and unexposed children selected for this study
were age-matched within each genotype.
Functional analysis
Ingenuity Pathway Analysis (IPA, Ingenuity Systems®)
was used for biological interpretation. The overlap be-
tween sig-DMPs and sig-DMRs was determined and
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used as input for canonical pathway analysis. A Fisher’s
exact test was used to determine whether the gene lists
include more genes associated with a given pathway as
compared to random chance (P value ≤ 0.05).
The DisGeNet platform (http://www.disgenet.org/)
was used to screen for gene disease associations [62].
The database (currently) contains 429111 gene disease
associations for which the platform provides a reli-
ability score (DisGeNET Score). This score ranges
from 0 to 1 and takes into account the number and
type of sources (level of curation, organisms), and the
number of publications supporting the association
(for further details we refer to the DisGeNet website).
For this manuscript, we extracted the associations
with a score above 0.1. By this criterion, 34180 gene
disease associations remain in the database. Associ-
ated diseases were mapped to the overlapping list of
genes between sig-DMPs and sig-DMRs.
Results
Descriptive statistics of the study population
Characteristics, inclusive anthropometric data, for the
48 children (6–11 years of age) are presented in Table 1.
In accordance with the findings for the whole cohort
[19], birth weights were significantly lower and mea-
sures of body composition (abdominal circumference,
skin fold thickness), increase in BMI Z score from birth
to school age (delta BMI Z score), diastolic blood pres-
sure, and leptin and insulin concentrations at school
age were significantly higher in the exposed PON1
192QR/RR group compared with the unexposed QR/
RR group. For children with the QQ genotype, none of
the variables was significantly affected by prenatal
pesticide exposure (P > 0.05).
Prenatal pesticide exposure-induced methylation changes
at CpG sites enriched in promoter regions in PON1 192R-
allele carriers
Genome-wide DNA methylation in whole blood samples
from the children was determined by Illumina 450 K
methylation arrays and differential methylation patterns
related to prenatal pesticide exposure and PON1 Q192R
genotype were analyzed. First differential methylation
was detected at the single CpG level using two multiple
linear regression models (Fig. 1). Because relative cell
type composition was not associated with pesticide
exposure and PON1 Q192R genotype (Additional file 5),
differences in cellular composition were not further con-
sidered in the workflow of statistical analysis. Allowing
effect modification by PON1 Q192R genotype, 767 sig-
DMPs were identified of which 128 were hypermethy-
lated and 639 hypomethylated in prenatally exposed
PON1 192R allele carriers. When effect modification was
not assumed, and the interaction term between exposure
and PON1 genotype was removed from the models, 70
sig-DMPs of which 44 were hypermethylated and 26
hypomethylated in prenatally exposed PON1 192R-allele
carriers were identified. Hierarchical clustering of the
samples using all the sig-DMPs demonstrated a clear
cluster of exposed PON1 192R-allele carriers (Fig. 2).
Confidence in detection of differentially methylated
genes was increased by further analysis showing that the
changes in methylation were not restricted to single
CpGs, but were often located in regions or so called dif-
ferentially methylated regions (DMRs). 5002 sig-DMRs
were identified, of which 2264 were hypermethylated
and 2738 hypomethylated in the exposed PON1 192R
carrier group compared to the other groups. Allowing
interaction between exposure and PON1 Q192R geno-
type to determine sig-DMPs, 547 out of 767 sites
Fig. 2 Heatmap clustering representation of the sig-DMPs. Heatmap of the methylation values from the sig-DMPs showing a clear cluster of prenatal
pesticide exposed PON1-192 R-carrier samples (orange group). Hierarchical clustering is based on the euclidean distance and average linkage metric.
Higher methylation values are colored in yellow, while lower methylation values are colored in blue
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(71.3%) were overlapping with the list of sig-DMRs
(Additional file 6). When effect modification was not
considered, 57 out of 70 sites (81.4%) were overlapping
(Additional file 7).
The pyrosequencing methylation percentages con-
firmed the robustness of Illumina results. They showed
significant positive correlations with the Illumina 450 K
beta values for all measured CpG probes (Fig. 3), except
for two probes in the LEP gene (cg00840332 and
cg26814075) which were borderline significant (P value:
0.07 and 0.16, respectively). The reason for this less
strong correlation between the Illumina and the pyrose-
quencing LEP methylation is probably the lower inter-
individual methylation variability in this region compared
to GPR39 and PPARG.
In accordance with the Illumina results, the pyrose-
quencing LEP methylation values were not associated
with pesticide exposure and/or PON1 Q192R geno-
type. Furthermore, the serum leptin concentrations
were not correlated with LEP methylation status (data
not shown). For GPR39, the region analyzed with
pyrosequencing contained three Illumina cg-probes
(cg17172683, cg11552903, and cg18444763), which
showed a high correlation (r > 0.78) between the Illu-
mina beta values and the pyrosequencing methylation
percentages. For most CpGs in the pyrosequencing
region, we could verify a significant exposure effect,
and in each CpG site, prenatally exposed children with
the QR/RR genotype had the lowest mean methylation
value (Additional files 8 and 9). In the PPARG pro-
moter, a region was selected containing one Illumina
cg-probe (cg01412654). Also here, the correlation
between the 450 K Illumina beta values and the
pyrosequencing methylation percentages was strong.
However, DNA methylation in this region was not as-
sociated with pesticide exposure and/or PON1 Q192R
genotype and did not correlate with PON1 activity
(data not shown). A region in the OPCML gene was
found to be higher methylated in prenatal pesticide-
exposed children carrying the PON1 192R-allele. The
significant interaction effect between pesticide expos-
ure and PON1 Q192R genotype could be successfully
verified by pyrosequencing. The pyrosequencing
methylation values were significantly higher methyl-
ated in exposed children compared to unexposed
children carrying the PON1 192R-allele for most of
the CpG sites in the region (Additional file 9).
Next, we questioned whether the sig-DMPs were
enriched or depleted in a specific genomic location
(Fig. 4). Sig-DMPs for which interaction between expos-
ure and PON1 Q192R genotype was seen, were enriched
in promoter regions (200 and 1500 bp upstream of tran-
scription start sites) and depleted in gene bodies, 3′
UTRs and intergenic regions. This was also evident
Fig. 3 Correlation between the Illumina 450 K beta values and the pyrosequencing methylation percentages. The Pearson’s correlation coefficient
for each CpG probe is indicated between brackets. CpG probes cg00840332, cg19594666, and cg26814075 are located in the LEP gene, cg17172683,
cg11552903, and cg18444763 in the GPR39 gene, cg01412654 in the PPARG gene, and cg06908202, and cg16919708 in the OPCML gene
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when we overlapped the sig-DMPs with different chro-
matin states, where we observed enrichment in active
and poised promoters, while DMPs were depleted in
regions like transcriptional elongation, weak transcribed,
and heterochromatin regions. Furthermore, DMPs were
significantly more located in CpG islands and less ob-
served in CpG poor regions. Sig-DMPs found in the
models without an interaction term were not enriched
or depleted in a particular genomic region.
We also looked for enrichment in TFBS using available
ChIP ENCODE data from the UCSC genome browser.
Thirty-nine of the 161 TFBS were significantly enriched for
the model with interaction (Bonferroni adjusted P value <
0.05) while no enrichment was found for the sig-DMPs
found in the model without interaction (Additional file 10).
DNA methylation differences were enriched for genes
involved in neuro-endocrine signaling pathways
Overlapping the list of sig-DMPs with the list of sig-DMRs
we obtained a robust and a high confidence list of differen-
tially methylated genes (N = 446). This list was used as an
input for ingenuity pathway analysis. The top enriched
canonical pathways (based on P value) were dopamine-
DARPP32 feedback cAMP signaling, corticotrophin releas-
ing hormone signaling, nNOS signaling in neurons, CDK5
signaling, and neuregulin signaling (Table 2). In the context
of this manuscript, other significantly enriched pathways
such as mTOR signaling (rank 9, −log(P value) = 1.85) and
type II diabetes mellitus signaling (rank 16, −log(P value) =
1.51) are also highly relevant.
DNA methylation (partially) mediates associations
between pesticide exposure and higher leptin
concentrations, body fat content, and delta BMI Z scores
The list of genes that overlaps between sig-DMPs (as
identified by the interaction model) and sig-DMRs
was also used as input for mediation analysis. We
identified, respectively, 20, 31, and 45 candidate
methylation marks that (partly) mediate the effect be-
tween pesticide exposure and serum leptin concentra-
tions; delta BMI Z score; and body fat content. Based
on applied cut-off criteria, we were not able to iden-
tify methylation marks that mediate the effect on
BMI Z score. Currently known gene disease associa-
tions allowed to extract mediators that were reported
to be involved in development of weight gain/obesity,
insulin resistance/diabetes, cardiovascular disease,
and/or fetal growth retardation. This subset of media-
tors is given in Table 3. Based on Baron and Kenny’s
steps to analyze mediation, the association between
pesticide exposure and delta BMI Z score was par-
tially mediated by hypomethylation of UQCRC2,
MTNR1B and GRIN2A, and by hypermethylation of
FABP4 and LRP8. Methylation of UQCRC2 and LRP8
was also a partial mediator in the association between
Fig. 4 Genomic location of sig-DMPs. DMPs were mapped to gene elements (top left), CpG islands (top right), and chromatin state segmentations
(bottom). Asterisks indicate significant enrichment or depletion in comparison with all Illumina probes (gray bars) measured by the Fisher’s exact
test (P value < 0.05). Sig–DMPs where the interaction term was significant (blue bars) showed an enrichment in promoter regions and CpG islands.
Sig-DMPs where no interaction was seen (orange bars) showed no significant enrichment or depletion in a particular genomic region
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pesticide exposure and body fat percentage. LRP8 was also
found to mediate the association between pesticide expos-
ure and serum leptin concentration. The P value for
significance of the causal mediation effect is included in
Table 3 and was below 0.1 for all mediators except for
UQCRC2 and GRIN2A. Irrespective of disease association
Table 2 Significant enriched Ingenuity canonical pathways
Rank Ingenuity canonical pathways −log(P value) Ratio Hyper-genes Hypo-genes
1 Dopamine-DARPP32 Feedback in cAMP signaling 3.98 0.07 CREB5, PPP2R2B,
CACNA1A
KCNJ2, NOS1, GRIN2A, GUCY1B3, ADCY2,
PRKCH, GNAI3, CACNA1D, PRKCG
2 Corticotropin releasing Hormone signaling 2.74 0.07 CREB5 JUND, NOS1, GUCY1B3, ADCY2, PRKCH,
GNAI3, PRKCG
3 nNOS signaling in neurons 2.61 0.11 CAPN3 NOS1, GRIN2A, PRKCH, PRKCG
4 CDK5 signaling 2.41 0.07 PPP2R2B, CACNA1A CDK5R1, NGFR, ITGA2, LAMB1, ADCY2
5 Neuregulin signaling 2.06 0.07 EGFR, ERBB3 CDK5R1, ITGA2, PRKCH, PRKCG
6 PCP pathway 2.06 0.08 JUND, FZD10, RSPO3, WNT7B, WNT9B
7 Maturity onset diabetes of young (MODY) signaling 2.03 0.14 CACNA1A GAPDH, CACNA1D
8 Regulation of eIF4 and p70S6K signaling 2.02 0.05 PPP2R2B, FAU RPS16, RPS13, RPS10, ITGA2, IRS1, RPS19
9 mTOR signaling 1.85 0.05 PPP2R2B, FAU RPS16, RPS13, RPS10, IRS1, PRKCH, RPS19, PRKCG
10 Amyotrophic lateral sclerosis signaling 1.84 0.06 CAPN3, CACNA1A NOS1, GRIN2A, NEFM, CACNA1D
11 NF-κB activation by viruses 1.8 0.07 ITGAV, CR2, ITGA2, PRKCH, PRKCG
12 Phosphatidylethanolamine biosynthesis III 1.7 1 PTDSS2
13 Role of CHK proteins in cell cycle checkpoint control 1.61 0.07 PPP2R2B, RFC4 E2F3, CHEK1
14 Synaptic long-term depression 1.6 0.05 IGF1R, PPP2R2B NOS1, GUCY1B3, PRKCH, GNAI3, PRKCG
15 ErbB signaling 1.53 0.06 EGFR, ERBB3 NCK2, PRKCH, PRKCG
16 Type II diabetes mellitus signaling 1.51 0.05 PKM NGFR, ADIPOR2, IRS1, PRKCH, PRKCG
17 G beta gamma signaling 1.49 0.06 EGFR ADCY2, PRKCH, GNAI3, PRKCG
18 p70S6K signaling 1.48 0.05 EGFR, PPP2R2B IRS1, PRKCH, GNAI3, PRKCG
19 Role of osteoblasts, osteoclasts, and
chondrocytes in rheumatoid arthritis
1.47 0.04 FZD10, NGFR, SMAD5, WNT7B, ITGA2, IL1RAP,
WNT9B, TCF7L2, NFATC1
20 Molecular mechanisms of cancer 1.46 0.04 RASGRF1, ITGA2, WNT7B, IRS1, E2F3, GNAI3,
FZD10, SMAD5, ADCY2, WNT9B, PRKCH,
CHEK1, PRKCG
21 nNOS signaling in skeletal muscle cells 1.45 0.13 CAPN3 NOS1
22 Factors promoting cardiogenesis in vertebrates 1.42 0.05 FZD10, SMAD5, PRKCH, TCF7L2, PRKCG
23 RAR activation 1.41 0.04 REL, ERCC2, SMAD5, NR2F1, ADCY2, PRKCH,
RARB, PRKCG
24 Choline degradation I 1.4 0.5 CHDH
25 Sulfate activation for sulfonation 1.4 0.5 PAPSS2
26 Mismatch repair in eukaryotes 1.4 0.13 RFC4 MLH1
27 Glioma signaling 1.37 0.05 IGF1R, EGFR PRKCH, E2F3, PRKCG
28 Netrin signaling 1.36 0.08 UNC5C, NCK2, NFATC1
29 Cellular effects of sildenafil (Viagra) 1.33 0.05 CACNG6, CACNA1A KCNN1, GUCY1B3, ADCY2, CACNA1D
30 GNRH signaling 1.33 0.05 EGFR, CREB5 ADCY2, PRKCH, GNAI3, PRKCG
31 Protein kinase A signaling 1.31 0.03 HIST1H1A, CREB5 PTPN9, TIMM50, NFATC1, GNAI3, AKAP12, NGFR,
PTP4A1, ADCY2, PRKCH, TCF7L2, PRKCG
32 Ovarian cancer signaling 1.31 0.05 EGFR FZD10, WNT7B, MLH1, WNT9B, TCF7L2
33 Colorectal cancer metastasis signaling 1.3 0.04 EGFR ADRBK1, APPL1, FZD10, WNT7B, MLH1, ADCY2,
WNT9B, TCF7L2
34 Agrin interactions at neuromuscular junction 1.3 0.06 EGFR, ERBB3 ITGA2, LAMB1
35 Growth hormone signaling 1.3 0.06 IGF1R IRS1, PRKCH, PRKCG
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of interest, the full list of potential mediators is provided
in Additional file 11 which also includes the outcome of
the statistical analysis.
DNA methylation at the PON1 promoter is affected by the
PON1-108CT SNP (rs705379) and negatively correlated
with paraoxonase 1 activity
Beside the genome-wide DNA methylation effects of
the PON1 Q192R genotype, we also observed a wide
variation in DNA methylation in the PON1 promoter
itself for nine Illumina cg-probes. Prenatal pesticide
exposure and/or PON1 Q192R genotype did not affect
PON1 promoter methylation status. However, another
polymorphism (rs705379, PON1 -108CT) in the pro-
moter region of PON1 could explain a large extent of
this variation (Fig. 5). Individuals homozygous for the
T-allele showed higher methylation values compared
with the homozygous C-allele carriers. As expected,
heterozygous individuals had an intermediate methyla-
tion value. Furthermore, the paraoxonase 1 activity
was significantly associated with DNA methylation in
the PON1 promoter region, with higher methylation
values resulting in lower paraoxonase 1 activity
(Fig. 6). PON1 Q192R genotype had the strongest
effect on PON1 activity, while variation in PON1
promoter methylation led to a smaller but significant
effect on PON1 activity.
Discussion
We found that prenatal pesticide exposure was associ-
ated with a differential DNA methylation profile in chil-
dren carrying the PON1 192R-allele compared to
children with the PON1 192QQ genotype and unex-
posed children. 767 sig-DMPs were identified of which
128 were hypermethylated and 639 hypomethylated in
prenatally exposed PON1 192R-allele carriers. The pro-
files of PON1 192R-allele carriers are clustered together.
As far as we know, our study is the first one to demon-
strate a link between epigenetics and genetic susceptibil-
ity towards pesticide exposure in fetal life. Our study
supports a linkage of a differential methylation pattern
and higher body fat content and serum leptin concentra-
tions in school age children dependent on both PON1
Q192R genotype and prenatal pesticide exposure.
The majority of the detected sig-DMPs were hypo-
methylated in exposed children with the PON1 192QR/
Fig. 5 Association between PON1 methylation and PON1 C-108T SNP. Individuals homozygous for the T allele showed higher methylation values
(beta values) as compared with C-allele carriers. P values shown are those from the one-way ANOVA analysis
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RR genotype. Interestingly, these DMPs were mainly lo-
cated in gene promoters, CpG islands and transcription
factor-binding sites, suggesting a possible direct link
with gene expression. To increase the confidence of our
findings, we also screened for differentially methylated
regions. Most of the single CpG sites were part of a
DMR suggesting that these were independent of tech-
nical variation and could be considered as reliable.
Technical reliability of the outcomes from the 450 K
Illumina methylation array was successfully confirmed
by bisulfite pyrosequencing of corresponding CpG probe
regions of four selected genes, i.e., LEP, PPARG, GPR39,
and OPCML for which corresponding probes were
available.
LEP was chosen because we previously found leptin to
be a potential mediator of the association between pre-
natal pesticide exposure and body fat accumulation in
children with the PON1 192R-allele [20]. In addition,
multiple studies demonstrated associations between LEP
DNA methylation and BMI, birth weight, and choles-
terol concentrations [42–44]. LEP was also found to be
differentially methylated in the offspring of mothers suf-
fering from the Dutch winter famine [45]. However, our
pyrosequencing results did not demonstrate a correl-
ation between leptin DNA methylation and leptin serum
concentrations, and prenatal pesticide exposure was not
associated with changes in leptin DNA methylation. This
suggests that the higher leptin concentration observed in
exposed children with the R-allele is not due to a direct
effect on DNA methylation of the leptin gene itself. An-
other gene whose methylation was confirmed by pyro-
sequencing was PPARG, a nuclear receptor controlling
the expression of genes involved in lipid storage and
glucose metabolism and target for obesogenic com-
pounds [50–53]. Furthermore, PPARγ is involved in the
regulation of PON1 expression [54–56]. However, we
did not find a correlation between PPARG DNA methy-
lation and PON1 activity (data not shown). In our
Fig. 6 Association between PON1 activity and PON1 methylation. The P values of the main effect for methylation are displayed using the linear
model PON1 activity ~M value + PON1-192 genotype + sex. Red colored samples are PON1 192 R-allele carriers, and samples in blue are children
with the PON1 192QQ genotype
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dataset, prenatal pesticide exposure did not seem to
change PPARG methylation levels irrespective of
PON1 Q192R genotype.
Reduced GPR39 DNA methylation observed in pre-
natally pesticide exposed R-allele carriers was confirmed
with pyrosequencing. GPR39 is receptor for obestatin (be-
longing to the ghrelin receptor family), involved in regula-
tion of appetite and glucose homeostasis [63, 64] and
associated with obesity [49]. Furthermore, GPR39 knock-
out mice showed an increased fat accumulation due to
changes in lipolysis and energy expenditure [49]. So, mis-
regulation of this gene due to methylation changes might
lead to an obese phenotype. To our knowledge, no other
study has yet reported methylation differences in this re-
gion associated with obesity or metabolic disorders or
showed links with pesticide exposure.
The higher methylation values of the OPCML DMR in
exposed children carrying the PON1 192R-allele could
be confirmed by pyrosequencing. OPCML encodes for a
protein belonging to the IgLON family. OPCML was
shown to be a tumor suppressor and inactivated by
DNA methylation in a variety of cancer types [65–68].
There is also a link with metabolic diseases, as SNPs in
this gene were found to be associated with obesity traits,
coronary artery calcified plaque, and visceral adipose/
subcutaneous adipose ratio [57–59].
Further analysis revealed that the differences in DNA
methylation were most pronounced in genes involved in
neuro-endocrine signaling pathways, including “dopa-
mine-DARPP32 feedback in cAMP signaling”, “cortico-
tropin releasing hormone signaling”, “nNOS signaling in
neurons”, and “CDK5 signaling”. These pathways are
important in the control of food intake and energy bal-
ance. Dopamine signaling, for example, is one of the key
players in the reward pathway, also controlling food
intake and preferences. Reduced dopamine signaling is
assumed to induce overeating [69, 70]. In mice, a high-
fat diet during pregnancy resulted in altered gene
expression and DNA methylation of the dopamine trans-
porter gene in the offspring, leading to an increased
preference for sucrose and fat [71]. Another study found
similar results in prenatally stressed rats given a high
fat-sucrose diet [72]. These studies suggest that prenatal
and early life conditions may influence food intake and
food preferences later in life through modulation of the
dopamine pathway [73–77]. Organophosphate insecti-
cides have been shown to modulate dopamine signaling
[78]. Furthermore, low-dose exposure of neonatal rats
caused metabolic dysfunction resembling prediabetes,
and in adulthood, exposed animals gained excess weight
when fed a high fat diet compared to unexposed rats on
the same diet [79].
Corticotropin-releasing hormone (CRH) is a neuro-
peptide secreted in response to stress. However, a role
for CRH in regulating energy balance and food intake
has also been described [80–82] including a relation to
the action of leptin [83].
Also NOS1 neurons are involved in energy balance
and food intake [84–86]. Knock-out of NOS1 in leptin
receptor- and NOS1-expressing hypothalamic neurons
results in hyperphagic obesity, decreased energy expend-
iture, and hyperglycemia in mice [85]. Interestingly,
organophosphates have been shown to alter NOS1-
expressing neurons during development in mice [87, 88].
Neureguline 1 treatment in rodents has been shown to
increase serum leptin concentrations, prevent weight
gain, and lower food intake. Hence, affecting this path-
way may also change food intake and energy metabolism
[89, 90].
A limitation of this study is that the methylation pro-
file is measured at the same time as health outcomes
and causality as such cannot be proven. Some of the
genes that relate to the sig-DMPs are involved in neuro-
endocrine pathways that regulate appetite and energy
balance, but this study cannot rule out if these sig-DMPs
are a consequence of alterations of food habits and phys-
ical activity among the exposed children with the PON1
192R-allele or an underlying mechanism. However, the
mediation analysis suggested that some of the differen-
tially methylated marks are on the mechanistic pathway
between prenatal pesticide exposure and the measured
outcomes. This result suggests that, at least in some,
CpG sites a change in methylation might contribute to
metabolic disturbances later in life. Furthermore, the
association was not significant between pesticide expos-
ure and BMI Z score as such, but between pesticide ex-
posure and delta BMI Z score which integrates fat
accumulation from birth and onwards to school age.
Interestingly, some of the mediator marks could be
linked to specific genes that were reported earlier to play
a role in the development of weight gain/obesity, insulin
resistance/diabetes, cardiovascular disease, and/or fetal
growth retardation: UQCRC2, MTNR1B, GRIN2A,
FABP4, and LRP8. FABP4 encodes for a member of the
fatty acid-binding protein family regulating lipid traffick-
ing, signaling, and metabolism. Different studies have
demonstrated the role of this protein in obesity, type 2
diabetes and atherosclerosis development [91–93]. In
ApoE deficient mice with hyperhomocysteine FABP4
DNA methylation is reduced in the aorta compared to
wild type mice, leading to a higher gene expression [94,
95]. UQCRC2 encodes a protein which is part of the
ubiquinol-cytochrome c reductase complex in the mito-
chondria. UQCRC2 was shown to be downregulated in
individuals who were susceptible to weight gain and
obesity development [96]. The melatonin receptor 1B
(MTNR1B) has a main function in regulating circadian
rhythm. Interestingly, several polymorphisms in the
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MTNR1B gene are associated with type 2 diabetes, fast-
ing glucose concentration, and insulin secretion [97–99].
GRIN2A encodes for a NMDA glutamate receptor sub-
unit. Polymorphisms in the GRIN2A gene are associated
with epilepsy and different neurological and mental
disorders [100–104]. A decreased gene expression of
GRIN2A in rats after intrauterine growth retardation
suggests a possible role for this gene in fetal growth and
development [105]. LRP8 encodes for a member of the
LDL receptor family. Common polymorphisms in the
LRP8 gene are associated with coronary artery disease,
myocardial infarction, and high birth weight [106–110].
Thus, the mediation analysis suggests a mechanistic role
of epigenetics in the development of an adverse metabolic
risk profile among the prenatally exposed children with
the PON1 R-allele as previously reported for these chil-
dren [19] and confirmed in the selected subset of children.
A few studies have investigated associations between
PON1 genotype and metabolic disturbances in children.
A recent study showed a higher risk of insulin resistance
(HOMA-IR) in Mexican children with the RR-genotype
as compared to children with the QQ or QR genotypes
although BMI did not differ between the groups [111].
Among Mexican-American children from an agricultural
community in California, a trend of increased BMI Z
scores with increased number of PON1 192Q alleles was
seen [112]. However, potential interactions between
PON1 genotype and prenatal exposure to pesticides, or
other environmental contaminants, were not investi-
gated in these studies. In our cohort, unexposed QQ-
homozygote children also tended to have higher body fat
content than unexposed R-carriers, but prenatally pesti-
cide exposed children with the R-allele accumulated
more fat during childhood and had a more unhealthy
metabolic risk profile at school age than unexposed chil-
dren and exposed children with the QQ genotype [19].
We also demonstrated that methylation in the PON1
promoter itself is affected by a SNP (PON1 -108CT,
rs705379). In addition, PON1 methylation values were
negatively associated with paraoxonase 1 activity. These
results are in agreement with the outcome of a recent
study from Huen and colleagues [113]. They found
methylation in the same nine CpG sites to be associated
with the PON1 -108CT polymorphism and also reported
an inverse association with AREase activity as a measure
of PON1 expression, both in newborns and 9-year-old
children. Furthermore, they demonstrated that PON1
methylation mediates the relationship between PON1
expression and the promoter -108 genotype. However,
the effect of prenatal pesticide exposure on the health
outcomes shown in Table 1 was not modulated by
PON1 -108CT genotype (data not shown).
Our findings indicate that the higher vulnerability
among children with the R-allele towards prenatal
pesticide exposure might be mediated by genotype-
specific epigenetic alterations. However, a limitation of
this study is that we cannot identify individual pesticides
related to these findings, since the study design did not
allow bio-monitoring of pesticide exposure in the
mothers, and the exposure classification of the mothers
encompassed more than 100 pesticides used in different
mixtures [11].
However, the existence of mixed exposure is a real-
world situation, and the longitudinal design, the blinded
exposure classification, and the blinded clinical examina-
tions, and genotyping minimized the possible impact of
exposure misclassification and bias.
Since PON1 is known to detoxify some organophos-
phate insecticides (e.g., chlorpyrifos), and these sub-
stances were frequently applied in the mothers’ working
areas, organophosphate insecticides could be assumed to
be responsible for the observed effects. However, the
mechanism is unclear and does not seem to be related
to the hydrolysis efficiency, since R-carriers have higher
paraoxonase activity than QQ homozygotes. Besides, at
relatively low exposure levels, as in this study, the cap-
acity to detoxify organophosphates is considered to be
independent of the PON1 Q192R genotype [114], and
furthermore, serum PON1 activity was reported to be
low in newborns and may be even lower before birth, as
indicated by lower activity in premature compared to
term babies [115, 116]. Thus, differences in fetal detoxi-
fication of pesticides related to PON1 genotype might
not be a likely explanation of the exposure-related differ-
ence in methylation pattern between children with the
QR/RR and QQ genotype.
Another limitation of the study is that DNA methyla-
tion analyses were performed in white blood cells as sur-
rogates for the target tissues. We do not know whether
the differences in DNA methylation patterns found in
blood mirror a similar change in adipose tissue, for ex-
ample. A recent study from Huang et al. demonstrated
several potential limitations in using methylation profiles
in blood to mirror the corresponding profile in target
tissues by comparing paired blood and adipose tissue
methylation profiles [117]. Furthermore, the compos-
ition of blood cell types may be variable and might affect
the DNA methylation analyses. In our dataset, prenatal
pesticide exposure and/or PON1 Q192R genotype did
not affect the relative blood cell counts determined by
the reference-based method of Houseman. Cell counts
were not included in the models due to the small sample
size of the study. Since we found that some of the health
effects (mainly leptin) were associated with cell type
count (Additional file 12), we cannot exclude that the
results of the mediation analysis were biased by differ-
ences in cell type composition. Based on the data of
Reinius et al. [39], methylation of only two CpG probes
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(cg18202502 and cg15134033) in Table 3 were slightly
associated with cell types (data not shown). Methylation
in the other CpG probes in Table 3 was not significantly
different between the blood cell types.
Finally, the small number of subjects included in this
exploratory study is a clear weakness because of the lim-
ited statistical power. Despite these constraints, our find-
ings suggest that DNA methylation might be a link
between prenatal pesticide exposure and cardio-
metabolic risk profile in children carrying the PON1
192R-allele. The findings deserve further investigation in
a larger study with quantitative data on pesticide expos-
ure. Whether this DNA methylation pattern is unique to
pesticide exposure or is shared by other adverse prenatal
environmental factors also needs further investigation.
Conclusions
In summary, our data indicate that DNA methylation
may be an underlying mechanism explaining an adverse
cardio-metabolic risk profile in prenatally pesticide-
exposed children carrying the PON1 192R-allele.
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